METTL3 and Sepsis: METTL3 is upregulated in most inflammatory diseases, indicating that it has pro-inflammatory effects; however, opposite expression trends in METTL3 expression have also been observed in the same diseases, including sepsis-related ARDS and OA, indicating that the effects of its expression may be related to cell type, modeling methods, disease status, or other potential regulatory factors.